| Primary |
| Contraception |
80.6% |
| Product Used For Unknown Indication |
10.9% |
| Drug Use For Unknown Indication |
4.8% |
| Pregnancy |
0.4% |
| Drug Exposure During Pregnancy |
0.4% |
| Menstrual Cycle Management |
0.4% |
| Epilepsy |
0.3% |
| Pain |
0.3% |
| Menorrhagia |
0.2% |
| Menstruation Irregular |
0.2% |
| Headache |
0.2% |
| Prophylaxis |
0.2% |
| Convulsion |
0.1% |
| Maternal Drugs Affecting Foetus |
0.1% |
| Maternal Exposure During Pregnancy |
0.1% |
| Menstrual Disorder |
0.1% |
| Hypersensitivity |
0.1% |
| Inflammatory Bowel Disease |
0.1% |
| Attention Deficit/hyperactivity Disorder |
0.1% |
| Dysmenorrhoea |
0.1% |
|
| No Adverse Event |
14.0% |
| Metrorrhagia |
11.1% |
| Weight Increased |
10.7% |
| Unintended Pregnancy |
8.6% |
| Medical Device Complication |
8.6% |
| Pregnancy With Implant Contraceptive |
6.4% |
| Menstruation Irregular |
6.4% |
| Product Quality Issue |
5.1% |
| Menorrhagia |
5.1% |
| Vaginal Haemorrhage |
3.4% |
| Weight Decreased |
3.0% |
| Pain In Extremity |
2.9% |
| Implant Site Pain |
2.5% |
| Incorrect Drug Administration Duration |
2.2% |
| Device Breakage |
2.0% |
| Nausea |
2.0% |
| Amenorrhoea |
1.7% |
| Vomiting |
1.5% |
| Haemorrhage |
1.5% |
| Mood Swings |
1.5% |
|
| Secondary |
| Contraception |
62.6% |
| Product Used For Unknown Indication |
10.0% |
| Hiv Infection |
4.9% |
| Drug Use For Unknown Indication |
3.9% |
| Antiviral Treatment |
3.7% |
| Epilepsy |
2.8% |
| Menstrual Cycle Management |
1.5% |
| Intracranial Pressure Increased |
1.3% |
| Menstruation Irregular |
1.0% |
| Crohn's Disease |
0.9% |
| Immunosuppression |
0.9% |
| Rheumatoid Arthritis |
0.9% |
| Endometriosis |
0.7% |
| Pregnancy |
0.7% |
| Renal Transplant |
0.7% |
| Type 1 Diabetes Mellitus |
0.7% |
| Headache |
0.6% |
| Hypersensitivity |
0.6% |
| Immunisation |
0.6% |
| Menstrual Disorder |
0.6% |
|
| Pregnancy With Implant Contraceptive |
17.6% |
| No Adverse Event |
16.2% |
| Product Quality Issue |
10.6% |
| Medical Device Complication |
8.9% |
| Weight Increased |
7.5% |
| Ectopic Pregnancy |
5.3% |
| Unintended Pregnancy |
5.0% |
| Metrorrhagia |
3.9% |
| Embolism Arterial |
2.8% |
| Vaginal Haemorrhage |
2.8% |
| Weight Decreased |
2.8% |
| Drug Exposure During Pregnancy |
2.5% |
| Implant Site Pain |
2.2% |
| Drug Interaction |
2.0% |
| Off Label Use |
2.0% |
| Peripheral Ischaemia |
2.0% |
| Menorrhagia |
1.7% |
| Device Breakage |
1.4% |
| Menstruation Irregular |
1.4% |
| Overdose |
1.4% |
|
| Concomitant |
| Contraception |
21.4% |
| Crohn's Disease |
16.6% |
| Product Used For Unknown Indication |
9.6% |
| Hepatitis C |
6.8% |
| Tuberous Sclerosis |
4.2% |
| Convulsion |
4.0% |
| Spondylitis |
4.0% |
| Depression |
3.8% |
| Anxiety |
3.6% |
| Hypothyroidism |
3.6% |
| Epilepsy |
3.2% |
| Osteoporosis |
3.2% |
| Lymphangioleiomyomatosis |
2.5% |
| Hiv Infection |
2.3% |
| Asthma |
2.1% |
| Multiple Myeloma |
2.1% |
| Pain |
2.1% |
| Endometriosis |
1.7% |
| Erythema |
1.5% |
| Oesophagitis |
1.5% |
|
| Pain In Extremity |
9.6% |
| Pericardial Effusion |
9.6% |
| No Adverse Event |
8.2% |
| Vertigo Positional |
6.8% |
| Pelvic Pain |
5.5% |
| Product Quality Issue |
5.5% |
| Pulmonary Embolism |
5.5% |
| Anal Abscess |
4.1% |
| Headache |
4.1% |
| Injury |
4.1% |
| Jaundice |
4.1% |
| Malaise |
4.1% |
| Oropharyngeal Blistering |
4.1% |
| Paraesthesia |
4.1% |
| Perineal Abscess |
4.1% |
| Pregnancy Test False Positive |
4.1% |
| Vaginal Haemorrhage |
4.1% |
| Affective Disorder |
2.7% |
| Ectopic Pregnancy |
2.7% |
| Fungal Infection |
2.7% |
|
| Interacting |
| Contraception |
26.9% |
| Antiretroviral Therapy |
20.0% |
| Hiv Infection |
20.0% |
| Product Used For Unknown Indication |
6.2% |
| Epilepsy |
5.4% |
| Antiviral Prophylaxis |
3.8% |
| Intracranial Pressure Increased |
2.3% |
| Asthma |
1.5% |
| Drug Use For Unknown Indication |
1.5% |
| Hiv Test |
1.5% |
| Hypothyroidism |
1.5% |
| Latent Tuberculosis |
1.5% |
| Migraine |
1.5% |
| Partial Seizures |
1.5% |
| Retroviral Infection |
1.5% |
| Depression |
0.8% |
| Drug Exposure During Pregnancy |
0.8% |
| Hereditary Angioedema |
0.8% |
| Smoking Cessation Therapy |
0.8% |
|
| Pregnancy With Implant Contraceptive |
23.1% |
| Drug Interaction |
15.4% |
| Ectopic Pregnancy |
12.8% |
| Pregnancy |
7.7% |
| Blood Thyroid Stimulating Hormone Increased |
5.1% |
| Dysmenorrhoea |
5.1% |
| Increased Tendency To Bruise |
5.1% |
| Abdominal Pain Lower |
2.6% |
| Amenorrhoea |
2.6% |
| Incorrect Drug Administration Duration |
2.6% |
| Maternal Exposure During Pregnancy |
2.6% |
| Polymenorrhoea |
2.6% |
| Pregnancy On Contraceptive |
2.6% |
| Ruptured Ectopic Pregnancy |
2.6% |
| Self-medication |
2.6% |
| Unintended Pregnancy |
2.6% |
| Vaginal Haemorrhage |
2.6% |
|
